Overview

Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
A double-blind, three-arm study, to evaluate the safety and efficacy of two dosing regimens of zabofloxacin (a fluoroquinolone antibiotic) in community acquired pneumonia.
Phase:
Phase 2
Details
Lead Sponsor:
IASO Pharma Inc.
Treatments:
Fluoroquinolones
Levofloxacin
Ofloxacin